Cyra-IT Capsule PR
Marketer
Systopic Laboratories Pvt Ltd
Salt Composition
Rabeprazole (20mg) + Itopride (150mg)
Overview Cyra-IT Capsule PR
Gastro-esophageal reflux disease (GERD) and peptic ulcers are effectively managed with Cyra-IT Capsule PR, a combination medication. This formulation alleviates symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration are determined by your physician and should be followed precisely. Treatment should continue as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common, typically transient side effects include abdominal pain, altered bowel habits (diarrhea or constipation), headache, gas, fatigue, and increased salivation. Report any concerning side effects immediately. Due to potential drowsiness and dizziness, avoid activities requiring alertness until the medicine's effects are known. Alcohol consumption should be avoided due to increased sleepiness risk. Lifestyle changes, such as consuming cold milk and avoiding stimulants (coffee, tea, spicy food, chocolate), can improve outcomes. Prior to commencing treatment, disclose any liver conditions, pregnancy, pregnancy planning, or breastfeeding to your doctor.
Uses of Cyra-IT Capsule PR
Acid reflux and peptic ulcers
Major Benefits of Cyra-IT Capsule PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Administer Cyra-IT Capsule PR on an empty stomach.
Common Side effects of Cyra-IT Capsule PR:
- Stomach pain
- Diarrhea
- Constipation
- Headache
- Dizziness
- Flatulence
- Weakness
- Flu-like symptoms
- Increased saliva production
How to use Cyra-IT Capsule PR:
Follow your doctor's instructions or consult the product label for usage guidance. Administer Cyra-IT Capsule PR on an empty stomach.
How Cyra-IT Capsule PR works:
Cyra-IT Capsule PR combines rabeprazole, a proton pump inhibitor (PPI), and itopride, a prokinetic agent. Rabeprazole lessens stomach acid production, providing relief from heartburn and acid indigestion. Itopride's action on the brain's vomiting center and the upper gastrointestinal tract enhances stomach and intestinal motility, facilitating smoother food passage.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Cyra-IT Capsule PR and alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Cyra-IT Capsule PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Cyra-IT Capsule PR usage while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Cyra-IT Capsule PR may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Cyra-IT Capsule PR use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Cyra-IT Capsule PR cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cyra-IT Capsule PR :
Should you forget a Cyra-IT Capsule PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cyra-IT Capsule PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently